Related Experiment Videos
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C
Cristina Rigamonti1, S Andorno, E Maduli
1Clinica Medica Generale, Università del Piemonte Orientale A. Avogadro, A.O. Maggiore della Carità, Corso Massini 18, 28100 Novara, Italy. crigamo@tin.it
Insights
In chronic hepatitis C patients with low disease grade, hepatic iron concentration is linked to liver fibrosis. This suggests iron may activate hepatic stellate cells, worsening liver damage and fibrosis progression.
Area of Science:
- Hepatology
- Gastroenterology
- Cell Biology
Background:
- Hepatic iron concentration correlates with liver fibrosis in chronic hepatitis C.
- The role of iron in exacerbating hepatitis C virus (HCV)-induced liver damage remains unclear.
- Investigating iron's impact on hepatic stellate cell activation and hepatocyte regeneration is crucial.
Purpose of the Study:
- To determine if hepatic iron concentration directly contributes to liver fibrosis in chronic hepatitis C.
- To explore the relationship between hepatic iron, hepatic stellate cell activation, and hepatocyte proliferation.
- To elucidate the mechanisms by which iron influences liver damage progression in HCV infection.
Main Methods:
- Studied 72 patients with chronic hepatitis C, staged using Ishak's score.
- Measured hepatic iron concentration via spectrophotometry.
- Assessed hepatic stellate cell activation (alpha-smooth muscle actin) and hepatocyte proliferation (Ki67).
- Determined serum iron and ferritin levels.
Main Results:
- Hepatic iron concentration showed significant correlations with serum ferritin levels (r=0.59), grading (r=0.47), and staging (r=0.51) in all patients.
- In patients with low grading scores (<3), hepatic iron concentration positively correlated with stellate cell number (r=0.55) and hepatocyte proliferation (r=0.36).
Conclusions:
- Hepatic iron may contribute to hepatic stellate cell activation in chronic hepatitis C patients with low disease grade.
- Iron accumulation could play a role in the progression of liver fibrosis in this patient group.
- Further research is warranted to confirm iron's direct role in fibrosis progression.
Background/Aims:
In patients with chronic hepatitis C, hepatic iron concentration correlates with liver fibrosis. However, it is not clear whether this correlation merely reflects the presence of more active disease, or iron exacerbates chronic hepatitis C virus (HCV)-induced damage through activation of hepatic stellate cells and regeneration of hepatocytes.
Materials And Methods:
We studied 72 HCV-positive patients, staged according to the Ishak's score system. We measured hepatic iron concentration with spectrophotometry and evaluated the number of hepatic stellate cells (using monoclonal antibody against alpha smooth muscle actin) and proliferating hepatocytes (using monoclonal antibody against Ki67). Iron and ferritin serum levels were also determined.
Results:
Hepatic iron concentration correlated statistically with ferritin serum level (r = 0.59, P < 0.001), with grading (r = 0.47, P < 0.001) and staging (r = 0.51, P < 0.001) scores for chronic hepatitis in the whole group of patients. Hepatic iron concentration correlated positively with stellate cell number (r = 0.55, P = 0.004) and Ki67-positive hepatocyte number (r = 0.36, P = 0.08) in patients with chronic hepatitis C and low grading score (< 3).
Conclusions:
In patients with chronic hepatitis C and low grading score, hepatic iron could play a role in the activation of hepatic stellate cells and in the progression of fibrosis.